Freedonia In The News

Article Title: US pharma excipients demand to reach $2 bn in 2018
Publication: Business Standard, 3/29/2014
Freedonia Study: Excipients (3146)

Quote from article
As per a new study, ‘Excipients’, of the Freedonia Group Inc, a Cleveland-based industry market research firm, the demand for pharmaceutical excipients in the US is projected to rise 4.3% per year to $2 billion in 2018. In volume terms, demand is expected to grow 1.9% annually to 900 million pounds over the same period. Emily Park, Analyst, Freedonia, said, “The best growth prospects are expected for products that offer a good balance among performance, compatibility with other excipients, and overall cost.”
Display Full Text of Article

Return to Document